keynote-177: final pfs analysis of pembrolizumab in patients with msi-h/dmmr mcrc
Published 3 years ago • 463 plays • Length 2:56
Download video MP4
Download video MP3
Similar videos
-
6:56
keynote-177 results: pembrolizumab versus chemotherapy for patients with msi-h/dmmr colorectal c...
-
3:44
keynote-177 & checkmate 142: checkpoint blockade in msi-h/dmmr crc
-
8:40
thierry andre, asco20: phase iii keynote-177 trial of pembrolizumab in metastatic colorectal cancer
-
6:57
keynote-177 discussion: chemo-immunotherapy, pseudoprogression & biomarkers
-
1:04
dr. halfdanarson on the keynote-177 trial in msi-h/dmmr mcrc
-
2:11
pembrolizumab vs. chemo in first-line mcrc
-
1:08
dr. ahn on the keynote-177 trial in newly diagnosed msi-h/dmmr mcrc
-
3:53
asco gi: updates in keynote-177, imbrave150 & claridhy
-
3:36
keynote-177: translating results for patients and clinicians
-
3:22
alan venook, md, on the keynote-177 study investigating msi high/mismatch repair deficient mcrc
-
5:20
pembrolizumab improves on chemo in msi-h/dmmr mcrc
-
0:53
dr. chu on the impact of the keynote-177 trial in mcrc
-
5:35
howard hochster, md, discusses the outcomes of the keynote-177 study in metastatic crc
-
7:37
dr. nazik hammad presents keynote-177 (gi cancer)
-
1:08
thierry andre, md, regarding the outcomes of the keynote-177 study in metastatic colorectal cancer
-
1:38
immuno-oncology in msi colorectal cancer
-
1:15
introduction to keynote-100 trial of pembrolizumab in advanced recurrent ovarian cancer
-
2:21
final analysis of keynote-585: pembrolizumab and chemotherapy in g/gej cancer
-
1:28
thierry andre, md, shares design of the keynote-177 study in metastatic colorectal cancer
Clip.africa.com - Privacy-policy